Gyros Protein Technologies AB has announced the launch of three service offerings to support the development and manufacturing of peptide-based drugs.

Icosagen Group has announced that it has acquired the LSA® platform from Carterra®.

HORIBA Scientific announces an expansion of the XGT-9000 series product line with the release of the two new micro-XRF (X-ray fluorescence) analyzers, the XGT-9000 Pro and XGT-9000 Expert.

Agilent Technologies Inc. has announced the acquisition of e-MSion, an early-stage company behind the innovative electron capture dissociation technology known as the ExD cell.

In a joint effort to accelerate high-quality therapies to market, Nucleus Biologics, The Cell Performance Company™ and Stoic Bio have announced plans for a supply agreement with the Center for Breakthrough Medicines.

Thermo Fisher Scientific is providing proteomics and biopharmaceutical research laboratories with a new line of low-flow HPLC columns that improve separation performance and stability of biologically complex samples.

TransCure bioServices has developed cell line-derived xenograft mouse models that will change how researchers tackle the preclinical studies of cancer therapies to treat acute myeloid leukemia.

Vector Laboratories has announced the acquisitions of Click Chemistry Tools, a manufacturer of click chemistry linkers and labeling reagents, and Fluoroprobes.

Voltron Therapeutics, Inc. has signed a new Sponsored Research Agreement with the Vaccine and Immunotherapy Center at Massachusetts General Hospital, Harvard Medical School to initiate a pre-clinical immuno-oncology trial targeting prostate stem cell antigen in prostate, renal cell and urothelial cancers, adding important potential indications to its growing pipeline.

Terebellum, subsidiary of global specialty pharmacy and healthcare solutions organization AscellaHealth, is launching a strategic guide to help manufacturers bring rare disease products to market.